Ezra E.W. Cohen

37.7k citations
421 papers · 16.9k indexed · 6 hit papers · h-index 67

Ezra E.W. Cohen

415 papers receiving 16.6k citations

Hit Papers

Cabozantinib in Progressive Medullary Thyroid Cancer200820262014202020132008201920112016250500750

Peers

Ezra E.W. Cohen
Comparison fields: 5 of 150
  • Oncology 8.5k
  • Pulmonary and Respiratory Medicine 5.6k
  • Otorhinolaryngology 4.7k
  • Molecular Biology 4.7k
  • Surgery 3.2k
Replace Lisa Licitra with:
Lisa Licitra Italy
Roger B. Cohen United States
William E. Gooding United States
Nancy Y. Lee United States
Bhuvanesh Singh United States
Christine H. Chung United States
Joseph A. Califano United States
Merrill S. Kies United States
Barbara Burtness United States
Carol R. Bradford United States
Ezra E.W. Cohen relative to Lisa Licitra Italy Lisa Licitra's profile →
Citations per field
00.5×1.5×
Lisa Licitra · 1×
Citations per year

Countries citing papers authored by Ezra E.W. Cohen

Since Specialization
Citations

This map shows the geographic impact of Ezra E.W. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezra E.W. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezra E.W. Cohen more than expected).

Fields of papers citing papers by Ezra E.W. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezra E.W. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezra E.W. Cohen. The network helps show where Ezra E.W. Cohen may publish in the future.

Co-authorship network of co-authors of Ezra E.W. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Ezra E.W. Cohen. A scholar is included among the top collaborators of Ezra E.W. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezra E.W. Cohen. Ezra E.W. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 48
3 141
4 83
5 46
6 16
7 106
8 4
9
Cabozantinib in Progressive Medullary Thyroid Cancerbreakdown →
850
10 120
11 51
12 64
13 15
14 51
15 211
16 67
17
Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Studybreakdown →
494
18 48
19 61
20 63

About Ezra E.W. Cohen

Ezra E.W. Cohen is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 421 papers that have together received 16.9k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (174 papers), Lung Cancer Treatments and Mutations (133 papers) and Cancer Immunotherapy and Biomarkers (94 papers). The work is most often cited by research in Otorhinolaryngology (4.7k citations), Oncology (8.5k citations) and Pulmonary and Respiratory Medicine (5.6k citations). Ezra E.W. Cohen has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Everett E. Vokes, Tanguy Y. Seiwert, Kerstin Stenson, Daniel J. Haraf, Loren K. Mell, Assuntina G. Sacco, Lisa Licitra, Steven I. Sherman, Mark W. Lingen and Lori J. Wirth. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026